Evidence map›Paper›PMID 39826130›Full record

ArticleCancer communications (London, England)2025

Inhibition of mTOR attenuates the initiation and progression of BRCA1-associated mammary tumors.

Hye Jung Baek, Geun Hee Han, Eun Joo Cho, Jihao Xu, Min Kyung Ki, Eun Jung Park, Tae Hyun Kim, Dong Hoon Shin, Heesun Cheong, Chu-Xia Deng and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer communications (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Hye Jung BaekResearch Institute, National Cancer Center, Goyang, South Korea.
Geun Hee HanSchool of Biological Sciences, Seoul National University, Seoul, South Korea.
Eun Joo ChoResearch Institute, National Cancer Center, Goyang, South Korea.
Jihao XuDepartment of Microbiology and Molecular Genetics, College of Biological Sciences, University of California, Davis, USA.
Min Kyung KiResearch Institute, National Cancer Center, Goyang, South Korea.
Eun Jung ParkResearch Institute, National Cancer Center, Goyang, South Korea.
Tae Hyun KimResearch Institute, National Cancer Center, Goyang, South Korea.
Dong Hoon ShinResearch Institute, National Cancer Center, Goyang, South Korea.
Heesun CheongResearch Institute, National Cancer Center, Goyang, South Korea.
Chu-Xia DengCancer Centre, Faculty of Health Sciences, University of Macau, Macau, P. R. China.ORCID https://orcid.org/0000-0001-8033-3902
Sung Chul LimDepartment of Pathology, College of Medicine, Chosun University, Gwangju, South Korea.
Chang-Il HwangDepartment of Microbiology and Molecular Genetics, College of Biological Sciences, University of California, Davis, USA.
Daehee HwangSchool of Biological Sciences, Seoul National University, Seoul, South Korea.
Sang Soo KimResearch Institute, National Cancer Center, Goyang, South Korea.ORCID https://orcid.org/0000-0002-4079-2503

Funding

National Cancer Center of Korea NCC-2210680/2410880National Research Foundation of Korea 2023R1A2C1004000
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39826130
PMCPMC11999881

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.